Published in J Med Genet on October 01, 1999
Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure. Hum Mol Genet (2008) 1.15
Contemporary genetic technologies and female reproduction. Hum Reprod Update (2011) 0.95
Genetics of primary ovarian insufficiency: a review. J Assist Reprod Genet (2014) 0.85
Premature ovarian failure: a critical condition in the reproductive potential with various genetic causes. Int J Fertil Steril (2014) 0.83
Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause. Biol Reprod (2015) 0.78
Drosophila lilliputian is required for proneural gene expression in retinal development. Dev Dyn (2012) 0.77
A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency. Panminerva Med (2014) 0.75
Incidence of premature ovarian failure. Obstet Gynecol (1986) 4.64
Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82
Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell (1993) 3.28
A mechanism for deletion formation in DNA by human cell extracts: the involvement of short sequence repeats. Nucleic Acids Res (1992) 2.03
Fragile X premutation screening in women with premature ovarian failure. Hum Reprod (1998) 1.99
Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet (1998) 1.84
Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet (1996) 1.64
Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet (1996) 1.61
Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet (1996) 1.52
FRAXE and mental retardation. J Med Genet (1995) 1.27
Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. Am J Hum Genet (1994) 1.11
Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. Genomics (1997) 1.05
Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: identification of a gene near FRAXE. Am J Hum Genet (1995) 0.92
Dynamic mutation loci: allele distributions in different populations. Ann Hum Genet (1996) 0.84
Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities. Am J Med Genet (1996) 0.84
A survey of FRAXE allele sizes in three populations. Am J Med Genet (1996) 0.84
Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles. Am J Med Genet (1997) 0.82
Clinical, cytogenetic, and molecular analysis of three families with FRAXE. J Med Genet (1997) 0.81
Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth (1991) 4.40
Assertive community treatment for frequent users of psychiatric hospitals in a large city: a controlled study. Am J Community Psychol (1990) 4.33
Homology of 54K protein of signal-recognition particle, docking protein and two E. coli proteins with putative GTP-binding domains. Nature (1989) 4.05
Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82
Von Hippel-Lindau disease: a genetic study. J Med Genet (1991) 3.61
Effective immunity to dental caries: protection of gnotobiotic rats by local immunization with Streptococcus mutans. J Immunol (1975) 2.71
Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut (1999) 2.28
Time course of response to prednisolone in chronic airflow obstruction. Thorax (1981) 2.28
Hardy-Weinberg quality control. Ann Hum Genet (1999) 2.22
The effect of component size and orientation on the concentrations of metal ions after resurfacing arthroplasty of the hip. J Bone Joint Surg Br (2008) 2.20
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
An assessment of grip strength measurement in rheumatoid arthritis. Scand J Rheumatol (1974) 2.08
Hydatidiform mole in England and Wales 1973-83. Lancet (1986) 2.05
Fragile X premutation screening in women with premature ovarian failure. Hum Reprod (1998) 1.99
Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J (1973) 1.97
The 54-kD protein of signal recognition particle contains a methionine-rich RNA binding domain. J Cell Biol (1990) 1.95
The Src family tyrosine kinase Fyn regulates natural killer T cell development. J Exp Med (1999) 1.95
Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet (1998) 1.84
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Corrosion at the neck-stem junction as a cause of metal ion release and pseudotumour formation. J Bone Joint Surg Br (2012) 1.75
Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol (1985) 1.71
A clinical assessment of nine pregnancies obtained by in vitro fertilization and embryo transfer. Fertil Steril (1981) 1.67
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
Do first impressions count? A comparison of subjective and psychologic assessment of spinal patients. Eur Spine J (1998) 1.64
Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet (1996) 1.64
Williams syndrome: use of chromosomal microdeletions as a tool to dissect cognitive and physical phenotypes. Am J Hum Genet (1999) 1.62
Non-disjunction of chromosome 18. Hum Mol Genet (1998) 1.62
Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet (2000) 1.55
Evaluation of digital joint circumference measurements in rheumatoid arthritis. Scand J Rheumatol (1973) 1.54
Consumer preferences in format and type of community-based weight control programs. Am J Health Promot (1998) 1.51
FRAXA and FRAXE: the results of a five year survey. J Med Genet (2000) 1.50
Geographical variation in the incidence of diabetes mellitus in Scottish children during the period 1977-1983. Diabet Med (1988) 1.49
Asthma in Greenwich, UK: impact of the disease and current management practices. Eur Respir J (1997) 1.48
A comparison of biopsy results using rigid and fibreoptic bronchoscopes. Br J Dis Chest (1980) 1.47
Adverse effects of inhaled corticosteroids. BMJ (1989) 1.44
Vasculitis presenting as chronic unilateral painful leg swelling. J Rheumatol (1988) 1.43
Recovery of plasma corticotrophin and cortisol levels after three-week course of prednisolone. Thorax (1981) 1.42
Voxel based morphometry of grey matter abnormalities in patients with medically intractable temporal lobe epilepsy: effects of side of seizure onset and epilepsy duration. J Neurol Neurosurg Psychiatry (2002) 1.42
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicentre study. J Clin Endocrinol Metab (1996) 1.41
The absorption of maltose and lactose in man. Clin Sci (1967) 1.41
Elastin: mutational spectrum in supravalvular aortic stenosis. Eur J Hum Genet (2000) 1.40
Evaluation of myocardial infarction therapy at a Canadian tertiary referral hospital. Can J Cardiol (1995) 1.38
Demostration of smooth muscle contractile protein antigens in liver and epithelial cells. Ann N Y Acad Sci (1975) 1.38
Rapid recovery after oxford unicompartmental arthroplasty through a short incision. J Arthroplasty (2001) 1.38
Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science (1981) 1.37
Genetic identification of a novel hantavirus of the harvest mouse Reithrodontomys megalotis. J Virol (1994) 1.34
Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch Toxicol (1990) 1.26
A role for FGF-8 in the initiation and maintenance of vertebrate limb bud outgrowth. Curr Biol (1995) 1.26
Evaluation of VP22 spread in tissue culture. J Virol (2000) 1.25
The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Allergy Clin Immunol (1997) 1.25
Preliminary results of a district call scheme for cervical screening organised in general practice. BMJ (1988) 1.19
The Lotus japonicus LjSym4 gene is required for the successful symbiotic infection of root epidermal cells. Mol Plant Microbe Interact (2000) 1.19
Jejunal disaccharidases and some observations on the cause of lactase deficiency. Br Med J (1966) 1.19
Situational predictors of sexual risk episodes among men with HIV who have sex with men. Sex Transm Infect (2008) 1.15
A model for joint working. J R Coll Gen Pract (1988) 1.12
Molecular abnormalities of collagen: a review. J R Soc Med (1983) 1.10
Hypergastrinaemia in rheumatoid arthritis: disease or iatrogenesis. Br Med J (1973) 1.08
Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique. J Clin Pathol (2005) 1.08
The short form-36 health survey questionnaire in spine surgery. J Bone Joint Surg Br (1997) 1.07
Response of rheumatoid arthritis to chemotherapy for Hodgkin's disease in a patient with IgA deficiency and overlap connective tissue disease. Ann Rheum Dis (1988) 1.07
How easily can practices be contacted during normal working hours? J R Coll Gen Pract (1988) 1.07
Localization of smooth muscle-like contractile proteins in kidney by immunoelectron microscopy. J Anat (1976) 1.07
Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study. J Med Genet (2007) 1.07
Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis. J Rheumatol (1976) 1.06
Immunologic findings in idiopathic cardiomyopathy. Am Heart J (1969) 1.05
Severe hypercapnia associated with a non-respiratory alkalosis. Br J Dis Chest (1978) 1.05
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging (2005) 1.04
A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function. J Biol Chem (1999) 1.04
No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers. Am J Hum Genet (2000) 1.03
Mössbauer spectroscopic studies of the cores of human, limpet and bacterial ferritins. Biochim Biophys Acta (1986) 1.02
Characterization of putative stem cells in isolated human colonic crypt epithelial cells and their interactions with myofibroblasts. Am J Physiol Cell Physiol (2008) 1.02
Fibre type changes in striated muscle of alcoholics. J Clin Pathol (1981) 1.02
Transmission of breast cancer--a controversy resolved. Clin Genet (1992) 1.02
Partial purification of anti-DNA antibodies from systemic lupus erythematosus serum by dye-ligand chromatography. J Immunol Methods (1982) 1.01
Mistreatment due to weight: prevalence and sources of perceived mistreatment in women and men. Obes Res (1999) 1.01
Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol (2008) 1.00
Organ-specific crystalline structures of ferritin cores in beta-thalassemia/hemoglobin E. Biol Met (1991) 1.00
Abdominal apoplexy in rheumatoid arthritis. Australas Ann Med (1970) 1.00
A mono-sited transferrin from a representative deuterostome: the ascidian Pyura stolonifera (subphylum Urochordata). Blood (1984) 1.00
Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II). Biol Met (1989) 1.00
Synthetic applications of heteroaromatic betaines with six-membered rings. Angew Chem Int Ed Engl (1976) 1.00
An audit of tunnel position in anterior cruciate ligament reconstruction. Knee (2001) 1.00
Osteopenia as a feature of the androgen insensitivity syndrome. Clin Endocrinol (Oxf) (1995) 1.00
Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features. Ann Rheum Dis (1992) 0.99
Brown-Sequard syndrome after management of vertebral hemangioma with intralesional alcohol. A case report. Spine (Phila Pa 1976) (1999) 0.99
Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril (1999) 0.99
Dramatic and rapid shrinkage of a massive invasive prolactinoma with bromocriptine: a case report. Clin Endocrinol (Oxf) (1985) 0.99
Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. Ann Rheum Dis (1987) 0.98
Association between - 308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthma. Clin Exp Allergy (1999) 0.98
Spontaneous coronary artery dissection in young women. Cathet Cardiovasc Diagn (1996) 0.98
Clinical significance of native DNA antibodies in systemic lupus erythematosus and other connective tissue diseases. Scott Med J (1974) 0.97
Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry (1995) 0.97
Treatment of xerostomia: a double-blind trial in 108 patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol (1981) 0.96
The importance of prudent negative consequences for maintaining the appropriate behavior of hyperactive students. J Abnorm Child Psychol (1984) 0.96
Brief interventions and alcohol use. Qual Health Care (1993) 0.96
Development of three copper metalloenzymes in clover leaves. Plant Physiol (1985) 0.96
In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases. Clin Exp Immunol (1979) 0.95
Preliminary observations on possible premalignant changes in bone marrow adjacent to worn total hip arthroplasty implants. Clin Orthop Relat Res (1996) 0.95
Cystic fibrosis mutation analysis: report from 22 U.K. regional genetics laboratories. Hum Mutat (1995) 0.94